Cat. #153650
Anti-Growth Differentiation Factor 9B [28A]
Cat. #: 153650
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Growth Differentiation Factor 9B
Class: Monoclonal
Application: ELISA ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: BioServ UK Ltd
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Growth Differentiation Factor 9B [28A]
- Alternate name: Bone morphogenetic protein 15, BMP-15, Growth/differentiation factor 9B, GDF9B
- Research fields: Cancer;Developmental biology
- Clone: 28A
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 55 kDa
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; WB
- Description: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.
- Immunogen: Recognizes sequence SAEVTASSSKHSGPENNQC on the C-terminus of human GDF9B (BMP15)
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: Growth Differentiation Factor 9B
- Molecular weight: 55 kDa
- Target background: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.
Applications
- Application: ELISA ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C
References
- Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence.
- Sudiman et al. 2014. PLoS One. 9(7):e103563. PMID: 25058588.
- Al-Musawi et al. 2013. Endocrinology. 154(2):888-99. PMID: 23284103.
- Species differences in the expression and activity of bone morphogenetic protein 15.
- Pulkki et al. 2011. Mol Cell Endocrinol. 332(1-2):106-15. PMID: 20937357.
- The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region.
